The history of the HSV amplicon: From naturally occurring defective genomes to engineered amplicon vectors

Current Gene Therapy

Volumn 6, Issue 3, 2006, Pages 277-301

  Frenkel, Niza ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Amplicon; Cleavage packaging; Concatemer; Foreign gene; Helper virus; Origin; oriL; oriS; Pac 1; Pac 2; Rolling circle; Transgene

Indexed keywords

BETA GALACTOSIDASE; CIS ACTING ELEMENT; OVALBUMIN; PROTEIN P53; VIRUS DNA; VIRUS VECTOR;

AMPLICON; DEFECTIVE VIRUS; DNA RECOMBINATION; DNA REPLICATION ORIGIN; DNA SEQUENCE; DNA STRUCTURE; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC CONSERVATION; GENETIC ENGINEERING; GENETIC TRANSFECTION; HELPER VIRUS; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES VIRUS; HOST CELL; IN VITRO STUDY; INVERTED REPEAT; MOLECULAR CLONING; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; SUPERINFECTION; TARGET CELL; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME; VIRUS INFECTION; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

BASE SEQUENCE; GENETIC ENGINEERING; GENETIC VECTORS; GENOME, VIRAL; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; MOLECULAR SEQUENCE DATA; SIMPLEXVIRUS;

SIMPLEXVIRUS;

EID: 33745215409     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652306777591992     Document Type: Review

References (94)

1. Balliet, J. W., Min, J. C., Cabatingan, M. S., and Schaffer, P. A. (2005). Site-directed mutagenesis of large DNA palindromes: construction and in. vitro characterization of herpes simplex virus type 1 mutants containing point mutations that eliminate the oriL or oriS initiation function. J. Virol. 79(20), 12783-97.
2. Balliet, J. W., and Schaffer, P. A. (2006). Point mutations in herpes simplex virus type 1 oriL, but not in oriS, reduce pathogenesis during acute infection of mice and impair reactivation from latency. J. Virol. 80(1), 440-50.
3. Bankier, A. T., Dietrich, W., Baer, R., Barrell, B. G., Colbere-Garapin, F., Fleckenstein, B., and Bodemer, W. (1985). Terminal repetitive sequences in herpesvirus saimiri virion DNA. J. Virol. 55(1), 133-9.
4. Barzilai, A., Zivony-Elbom, I., Sarid, R., Noah, E., and Frenkel, N. (2006). The herpes simplex virus type 1 vhs-UL41 gene secuRes. viral replication by temporarily evading apoptotic cellular Res.ponse to infection: Vhs-UL41 activity might require interactions with elements of cellular mRNA degradation machinery. J. Virol. 80(1), 505-13.
5. Ben-Porat, T., and Tokazewski, S. A. (1977). Replication of herpesvirus DNA. II. Sedimentation characteristics of newly synthesized DNA. Virology 79(2), 292-301.
6. Bergsma, D. J., Olive, D. M., Hartzell, S. W., and Subramanian, K. N. (1982). Territorial limits and functional anatomy of the simian-virus 40 replication origin. In "Proc Natl Acad Sci USA", Vol. 79, pp. 381-5.
7. Borenstein, R., Singer, O., Moseri, A., and Frenkel, N. (2004). Use of amplicon-6 vectors derived from human herpesvirus 6 for efficient expRes.sion of membrane-associated and -secreted proteins in T cells. J. Virol. 78(9), 4730-43.
8. Chahlavi, A., Todo, T., Martuza, R. L., and Rabkin, S. D. (1999). Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma. Neoplasia 1(2), 162-9.
9. Challberg, M. D. (1986). A method for identifying the viral genes required for herpesvirus DNA replication. Proc. Natl. Acad. Sci. USA 83(23), 9094-8.
10. Chou, J., and Roizman, B. (1985). Isomerization of herpes simplex virus 1 genome: identification of the cis-acting and recombination sites within the domain of the a sequence. Cell 41(3), 803-11.
11. Clements, J. B., Cortini, R., and Wilkie, N. M. (1976). Analysis of herpesvirus DNA substructure by means of Res.triction endonucleases. J. Gen. Virol. 30(2), 243-56.
12. Dabrowski, C. E., Carmillo, P. J., and Schaffer, P. A. (1994). Cellular protein interactions with herpes simplex virus type 1 oriS. Mol. Cell. Biol 14(4), 2545-55.
13. Dabrowski, C. E., and Schaffer, P. A. (1991). Herpes simplex virus type 1 origin-specific binding protein: oriS-binding properties and effects of cellular proteins. J. Virol. 65(6), 3140-50.
14. Dambach, M. J., Trecki, J., Martin, N., and Markovitz, N. S. (2006). Oncolytic Viruses Derived from the gamma34.5-Deleted Herpes Simplex Virus Recombinant R3616 Encode a Truncated UL3 Protein. Mol. Ther 13(5), 891-8.
15. Davison, A. J. (1984). Structure of the genome termini of varicella-zoster virus. J. Gen. Virol. 65 (Pt11), 1969-77.
16. Davison, A. J., and Wilkie, N. M. (1981). Nucleotide sequences of the joint between the L and S segments of herpes simplex virus types 1 and 2. J. Gen. Virol. 55(Pt 2), 315-31.
17. Deb, S., and Deb, S. P. (1989). Analysis of Ori-S sequence of HSV-1: identification of one functional DNA binding domain. Nucleic Acids. Res. 17(7), 2733-52.
18. Deiss, L. P., Chou, J., and Frenkel, N. (1986). Functional domains within the a sequence involved in the cleavage-packaging of herpes simplex virus DNA. J. Virol. 59(3), 605-18.
19. Deiss, L. P., and Frenkel, N. (1986). Herpes simplex virus amplicon: cleavage of concatemeric DNA is linked to packaging and involves amplification of the terminally reiterated a sequence. J. Virol. 57(3), 933-41.
20. Elias, P., and Lehman, I. R. (1988). Interaction of origin binding protein with an origin of replication of herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 85(9), 2959-63.
21. Fraefel, C., Song, S., Lim, F., Lang, P, Yu, L., Wang, Y., Wild, P., and Geller, A. I. (1996). Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J. Virol. 70(10), 7190-7.
22. Frenkel, N. (1981). "Defective interfering herpes viruses." The Human Hepesviruses - an interdisciplinary prospective. (W. R. D. A.J. Nahmias, and R.R.Schinazy (ed), Ed.) Elsevier/North Holland Puclishing Co., New York, New York.
23. Frenkel, N., Jacob, R. J., Honess, R. W., Hayward, G. S., Locker, H., and Roizman, B. (1975). Anatomy of herpes simplex virus DNA. III. Characterization of defective DNA molecules and biological properties of virus populations containing them. J. Virol. 16(1), 153-67.
24. Frenkel, N., Lavi, S., and Winocour, E. (1974). The host DNA sequences in different populations of serially passaged SV40. Virology 60(1), 9-20.
25. Frenkel, N., Locker, H., Batterson, W., Hayward, G. S., and Roizman, B. (1976). Anatomy of herpes simplex virus DNA. VI. Defective DNA originates from the S component. J. Virol. 20(2), 527-31.
26. Frenkel, N., Locker, H., and Vlazny, D. A. (1980). Studies of defective herpes simplex viruses. Ann. N. Y. Acad. Sci 354, 347-70.
27. Geller, A. I., Yu, L., Wang, Y., and Fraefel, C. (1997). Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders. Exp. Neurol 144(1), 98-102.
28. Gray, C. P., and Kaerner, H. C. (1984). Sequence of the putative origin of replication in the UL region of herpes simplex virus type 1 ANG DNA. J. Gen. Virol. 65 (Pt 12), 2109-19.
29. Halliburton, I. W., Randall, R. E., Killington, R. A., and Watson, D. H. (1977). Some properties of recombinants between type 1 and type 2 herpes simplex viruses. J. Gen. Virol. 36(3), 471-84.
30. Hammerschmidt, W., Ludwig, H., and Buhk, H. J. (1986). Short repeats cause heterogeneity at genomic terminus of bovine herpesvirus I. J. Virol. 58(1), 43-9.
31. Hardwicke, M. A., and Schaffer, P. A. (1995). Cloning and characterization of herpes simplex virus type 1 oriL: comparison of replication and protein-DNA complex formation by oriL and oriS. J. Virol. 69(3), 1377-88.
32. Hayward, G. S., Frenkel, N., and Roizman, B. (1975). Anatomy of herpes simplex virus DNA: strain differences and heterogeneity in the locations of Res.triction endonuclease cleavage sites. Proc. Natl. Acad. Sci. USA 72(5), 1768-72.
33. Hayward, G. S., Jacob, R. J., Wadsworth, S. C., and Roizman, B. (1975). Anatomy of herpes simplex virus DNA: evidence for four populations of molecules that differ in the relative orientations of their long and short components. Proc. Natl. Acad. Sci. USA 72(11), 4243-7.
34. Honess, R. W., and Roizman, B. (1973). Proteins specified by herpes simplex virus. XI. Identification and relative molar rates of synthesis of structural and nonstructural herpes virus polypeptides in the infected cell. J. Virol. 12(6), 1347-65.
35. Honess, R. W., and Roizman, B. (1975). Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requiRes. functional viral polypeptides. Proc. Natl. Acad. Sci. USA 72(4), 1276-80.
36. Isler, J. A., and Schaffer, P. A. (2001). Origin binding protein-containing protein-DNA complex formation at herpes simplex virus type 1 oriS: role in oriS-dependent DNA replication. J. Virol. 75(15), 6808-16.
37. Jacob, R. J., and Roizman, B. (1977). Anatomy of herpes simplex virus DNA VIII. Properties of the replicating DNA. J. Virol. 23(2), 394-411.
38. Kaerner, H. C., Maichle, I. B., Ott, A., and Schroder, C. H. (1979). Origin of two different classes of defective HSV-1 Angelotti DNA. Nucleic Acids. Res. 6(4), 1467-78.
39. Kaerner, H. C., Ott-Hartmann, A., Schatten, R., Schroder, C. H., and Gray, C. P. (1981). Amplification of a short nucleotide sequence in the repeat units of defective herpes simplex virus type 1 Angelotti DNA. J. Virol. 39(1), 75-81.
40. Kanai, R., Tomita, H., Shinoda, A., Takahashi, M., Goldman, S., Okano, H., Kawase, T., and Yazaki, T. (2006). Enhanced therapeutic efficacy of G207 for the treatment of glioma through Musashil promoter retargeting of gamma34.5-mediated virulence. Gene. Ther 13(2), 106-16.
41. Keller, J. M., Spear, P. G., and Roizman, B. (1970). Proteins specified by herpes simplex virus. 3. Viruses differing in their effects on the social behavior of infected cells specify different membrane glycoprotiens. Proc. Natl. Acad. Sci. USA 65(4), 865-71.
42. Kim, S. H., Wong, R. J., Kooby, D. A., Carew, J. F., Adusumilli, P. S., Patel, S. G., Shah, J. P., and Fong, Y. (2005). Combination of mutated herpes simpley virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck. Eur. J. Cancer 41(2), 313-22.
43. Knopf, C., Strauss, G., Ott-Hartmann, A., Schatten, R., and Kaerner, H. C. (1983). Herpes simplex virus defective genomes: structure of HSV-1 ANG defective DNA of class II and encoded polypeptides. J. Gen. Virol. 64 (Pt 11), 2455-70.
44. Koff, A., and Tegtmeyer, P. (1988). Characterization of major recognition sequences for a herpes simplex virus type 1 origin-binding protein. J. Virol. 62(11), 4096-103.
45. Kwong, A., and N. Frenkel (1995). "Biology of herpes simplex virus (HSV) defective viruses and development of the amplicon system." Viral vectors, Gene therapy and neuroscience application. Academic PRes.s, San Diego, Calif, 25-42.
46. Kwong, A. D., and Frenkel, N. (1984). Herpes simplex virus amplicon: effect of size on replication of constructed defective genomes containing eucaryotic DNA sequences. J. Virol. 51(3), 595-603.
47. Kwong, A. D., and Frenkel, N. (1985). The herpes simplex virus amplicon. IV. Efficient expRes.sion of a chimeric chicken ovalbumin gene amplified within defective virus genomes. Virology 142(2), 421-5.
48. Kwong, A. D., and Frenkel, N. (1987). Herpes simplex virus-infected cells contain a function(s) that destabilizes both host and viral mRNAs. Proc. Natl. Acad. Sci. USA 84(7), 1926-30.
49. Kwong, A. D., and Frenkel, N. (1989). The herpes simplex virus virion host shutoff function. J. Virol. 63(11), 4834-9.
50. Kwong, A. D., Kruper, J. A., and Frenkel, N. (1988). Herpes simplex virus virion host shutoff function. J. Virol. 62(3), 912-21.
51. Locker, H., and Frenkel, N. (1978). The DNA of serially passaged herpes simplex virus: organization, origin, and homology to viral RNA. IARC. Sci. Publ. 24 (Pt 1), 75-85.
52. Locker, H., and Frenkel, N. (1979a). BamI, KpnI, and Sall Res.triction enzyme maps of the DNAs of herpes simplex virus strains Justin and F: occurrence of heterogeneities in defined regions of the viral DNA. J. Virol. 32(2), 429-41.
53. Locker, H., and Frenkel, N. (1979b). Structure and origin of defective genomes contained in serially passaged herpes simplex virus type 1 (Justin). J. Virol. 29(3), 1065-77.
54. Locker, H., Frenkel, N., and Halliburton, I. (1982). Structure and expRes.sion of class II defective herpes simplex virus genomes encoding infected cell polypeptide number 8. J. Virol. 43(2), 574-93.
55. Makhov, A. M., Lee, S. S., Lehman, I. R., and Griffith, J. D. (2003). Origin-specific unwinding of herpes simplex virus 1 DNA by the viral UL9 and ICP8 proteins: visualization of a specific preunwinding complex. Proc. Natl. Acad. Sci. USA 100(3), 898-903.
56. Markert, J. M., Medlock, M. D., Rabkin, S. D., Gillespie, G. Y., Todo, T., Hunter, W. D., Palmer, C. A., Feigenbaum, F., Tornatore, C., Tufaro, F., and Martuza, R. L. (2000). Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: Res.ults of a phase I trial. Gene. Ther 7(10), 867-74.
57. Matsuo, T., Heller, M., Petti, L., O'Shiro, E., and Kieff, E. (1984). Persistence of the entire Epstein-Barr virus genome integrated into human lymphocyte DNA. Science 226(4680), 1322-5.
58. McReynolds, L., O'Malley, B. W., Nisbet, A. D., Fothergill, J. E., Givol, D., Fields, S., Robertson, M., and Brownlee, G. G. (1978). Sequence of chicken ovalbumin mRNA. Nature 273(5665), 723-8.
59. Mocarski, E. S., Deiss, L. P., and Frenkel, N. (1985). Nucleotide sequence and structural featuRes. of a novel US-a junction pRes.ent in a defective herpes simplex virus genome. J. Virol. 55(1), 140-6.
60. Mocarski, E. S., Post, L. E., and Roizman, B. (1980). Molecular engineering of the herpes simplex virus genome: insertion of a second L-S junction into the genome causes additional genome inversions. Cell 22(1 Pt 1), 243-55.
61. Mocarski, E. S., and Roizman, B. (1981). Site-specific inversion sequence of the herpes simplex virus genome: domain and structural featuRes. Proc. Natl. Acad. Sci. USA 78(11), 7047-51.
62. Mocarski, E. S., and Roizman, B. (1982a). Herpesvirus-dependent amplification and inversion of cell-associated viral thymidine kinase gene flanked by viral a sequences and linked to an origin of viral DNA replication. Proc. Natl. Acad. Sci. USA 79(18), 5626-30.
63. Mocarski, E. S., and Roizman, B. (1982b). Structure and role of the herpes simplex virus DNA termini in inversion, circularization and generation of virion DNA. Cell 31(1), 89-97.
64. Olivo, P. D., Nelson, N. J., and Challberg, M. D. (1988). Herpes simplex virus DNA replication: the UL9 gene encodes an origin-binding protein. Proc. Natl. Acad. Sci. USA 85(15), 5414-8.
65. Olivo, P. D., Nelson, N. J., and Challberg, M. D. (1989). Herpes simplex virus type 1 gene products required for DNA replication: identification and overexpRes.sion. J. Virol. 63(1), 196-204.
66. Poffenberger, K. L., and Roizman, B. (1985). A noninverting genome of a viable herpes simplex virus 1: pRes.ence of head-to-tail linkages in packaged genomes and requirements for circularization after infection. J. Virol. 53(2), 587-95.
67. Read, G. S., and Frenkel, N. (1983). Herpes simplex virus mutants defective in the virion-associated shutoff of host polypeptide synthesis and exhibiting abnormal synthesis of alpha (immediate early) viral polypeptides. J. Virol. 46(2), 498-512.
68. Roizman, B. (1979). The structure and isomerization of herpes simplex virus genomes. Cell 16(3), 481-94.
69. Roizman, B. (1982). "The family herpesviridae: general description, taxonomy, and classification." The herpesviruses (B. Roizman, Ed.), 1 Plenum Publishing Corp., New York.
70. Roizman, P. a. (2002). The Family Herpesviridae: A Brief Introduction, Fourth Edition ed. In "Fields VIROLOGY", Vol. Volume 2, Chapter 71, pp. pg 2221-2228. Lippincott - Raven publishers.
71. Romi, H., Singer, O., Rapaport, D., and Frenkel, N. (1999). Tamplicon-7, a novel T-lymphotropic vector derived from human herpesvirus 7. J. Virol. 73(8), 7001-7.
72. Schroder, C. H., Stegmann, B., Lauppe, H. F., and Kaerner, H. C. (1975). An unusual defective genotype derived from herpes simplex virus strain ANG. InterVirology 6(4-5), 270-84.
73. Song, T. J., Eisenberg, D. P., Adusumilli, P. S., Hezel, M., and Fong, Y. (2006). Oncolytic Herpes Viral Therapy is Effective in the Treatment of Hepatocellular Carcinoma Cell Lines. J. Gastrointest. Surg 10(4), 532-42.
74. Spaete, R. R., and Frenkel, N. (1982). The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector. Cell 30(1), 295-304.
75. Spaete, R. R., and Frenkel, N. (1985). The herpes simplex virus amplicon: analyses of cis-acting replication functions. Proc. Natl. Acad. Sci. USA 82(3), 694-8.
76. Stow, N. D. (1982). Localization of an origin of DNA replication within the TRS/IRS repeated region of the herpes simplex virus type 1 genome. EMBO J. 1(7), 863-7.
77. Stow, N. D., and McMonagle, E. C. (1983). Characterization of the TRS/ IRS origin of DNA replication of herpes simplex virus type 1. Virology 130(2), 427-38.
78. Strom, T., and Frenkel, N. (1987). Effects of herpes simplex virus on mRNA stability. J. Virol. 61(7), 2198-207.
79. Szostak, J. W., Orr-Weaver, T. L., Rothstein, R. J., and Stahl, F. W. (1983). The double-strand-break repair model for recombination. Cell 33(1), 25-35.
80. Terada, K., Wakimoto, H., Tyminski, E., Chiocca, E. A., and Saeki, Y. (2006). Development of a rapid method to generate multiple oncolytic HSV vectors and their in. vivo evaluation using syngeneic mouse tumor models. Gene. Ther 13(8), 705-14.
81. Toda, M., Iizuka, Y., Kawase, T., Uyemura, K., and Kawakami, Y. (2002). Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV. Cancer. Gene. Ther 9(4), 356-64.
82. Toda, M., Rabkin, S. D., Kojima, H., and Martuza, R. L. (1999). Herpes simplex. virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity. Hum. Gene. Ther 10(3), 385-93.
83. Todo, T., Rabkin, S. D., and Martuza, R. L. (2000). Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors. Cancer. Gene. Ther 7(6), 939-46.
84. Todo, T., Rabkin, S. D., SundaResan, P., Wu, A., Meehan, K. R., Herscowitz, H. B., and Martuza, R. L. (1999). Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus. Hum. Gene. Ther 10(17), 2741-55.
85. Varmuza, S. L., and Smiley, J. R. (1985). Signals for site-specific cleavage of HSV DNA: maturation involves two separate cleavage events at sites distal to the recognition sequences. Cell 41(3), 793-802.
86. Vlazny, D. A., and Frenkel, N. (1981). Replication of herpes simplex virus DNA: localization of replication recognition signals within defective virus genomes. Proc. Natl. Acad. Sci. USA 79(2), 742-6.
87. Vlazny, D. A., Kwong, A., and Frenkel, N. (1982). Site-specific cleavage/ packaging of herpes simplex virus DNA and the selective maturation of nucleocapsids containing full-length viral DNA. Proc. Natl. Acad. Sci. USA 79(5), 1423-7.
88. von-Magnus (1951a). Propagation of the PR8 strain of influenza A virus in chick embryos. III. Properties of the incomplete virus produced in serial passages of undiluted virus. Acta Pathol Microbiol Scand. 29(2), 157-181.
89. von-Magnus (1951b). Propagation of the PR8 strain of infuenza A virus in chick embryos. II. The formation of incomplete virus following inoculation of large doses of seed virus. Acta. Pathol. Microbiol. Scand. 28(3).
90. Wadsworth, S., Hayward, G. S., and Roizman, B. (1976). Anatomy of herpes simplex virus DNA. V. Terminally repetitive sequences. J. Virol. 17(2), 503-12.
91. Weir, H. M., Calder, J. M., and Stow, N. D. (1989). Binding of the herpes simplex virus type 1 UL9 gene product to an origin of viral DNA replication. Nucleic Acids. Res. 17(4), 1409-25.
92. Weir, H. M., and Stow, N. D. (1990). Two binding sites for the herpes simplex virus type 1 UL9 protein are required for efficient activity of the oriS replication origin. J. Gen. Virol. 71 (Pt 6), 1379-85.
93. Weller, S. K., Spadaro, A., Schaffer, J. E., Murray, A. W., Maxam, A. M., and Schaffer, P. A. (1985). Cloning, sequencing, and functional analysis of oriL, a herpes simplex virus type 1 origin of DNA synthesis. Mol. Cell. Biol 5(5), 930-42.
94. Winocour, E., Frenkel, N., Lavi, S., and Rozenblatt, S. (1974). SV40 DNA molecules which contain host cell DNA. Adv. Exp. Med. Biol 44(1), 291-3.